MDGN-201

N/A

Report date: 2024/08/29 17:59:51

Base Information

Drug NameMDGN-201
Drug Alias NameMDGN-201 TARGTepo secreting EPOTARGTEPOEpodureMDGN-201
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionErythropoiesis stimulantsGene transference
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemiaKidney Failure, ChronicRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAevi Genomic Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAevi Genomic Medicine LlcMedgenics Medical Israel Ltd
Active IndicationsN/A
Inactive IndicationsAnemiaKidney Failure, ChronicRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A